Laser vision correction procedures increased 13.7 percent year over year.
New CEO may end deal, as he looks to move away from disruptive nine-month period.
CEO said the funding will go toward buying back shares, paying down debt, and creating growth, which will include M&A deals.
The move followed news that Acucela’s emixustat missed its primary endpoint in a Phase IIb/III trial for GA.
The biopharmaceutical company lowered the proposed deal size prior to launching the offering.
The country’s expanding economy is leading to increased government spending on eye care.
Revenues are expected to total $1.6 billion in 2016.
The jet’s telemedicine platform will allow surgeons to continue mentoring students around the world after the plane has moved on, an Orbis official said.
The company founder said in 2015 that about 500 doctors, including 200 ophthalmologists, had invested.
The drugmaker is only the third sponsor in 75 years of the nation's oldest high school science competition.
Country faces myopia rate of more than 50 percent in four years, based on current trends.
You are not currently logged in.
©2018 Market Scope
Lost your Password